fda cleared semaglutide immunoassay Compounded "semaglutide" is not FDA-approved More than half of all

Therapeutic dose: 2.4 mg once a week

Get Started Semaglutide is a medication prescribed for weight loss and insulin management for diabetics and people diagnosed as obese

Injectable Wegovy has demonstrated robust weight loss outcomes in clinical trials

However, compounded products are not individually FDA-tested for potency and sterility the way brand-name products are, which is why choosing a pharmacy with third-party COA testing matters

GLP-1 and GIP Agonists: Semaglutide and Tirzepatide Semaglutide (found in medications like Ozempic and Wegovy) and Tirzepatide (Mounjaro) are incretin-based medications used to improve blood sugar regulation and support weight loss